4 terminated. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 3 | 1 | Terminated 1 |
Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omega 3 FA Supplements as Augmentation in the Treatment of Depression Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid supplement) - Major Depression, Cancer | Phase 2 / Phase 3 | Terminated | UConn Health | 6 | 2013-02-01 | 2017-12-27 |
| Study of Depression-Ketamine-Brain Function Ketamine - Major Depression | Phase 2 | Terminated | Markus KOSEL | 10 | 2010-06-01 | 2015-12-07 |
| Family Based Treatment of Depressed Adolescents Attachment Based Family therapy (ABFT) - Depressive Disorder, Mood Disorder | Phase 2 | Terminated | Helse Stavanger HF | 20 | 2008-06-01 | 2015-07-31 |
| Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder DU125530, Placebo - Major Depression | Phase 2 | Terminated | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 50 | 2004-05-01 | 2010-05-07 |
Depressive Disorder, Major (4) · Depression (3) · Cardiovascular Diseases (1) · Depressive Disorder (1) · Diabetes Mellitus (1) · Hypertension (1) · Mood Disorders (1) · Neoplasms (1)
Mental Disorders (4) · Behavior (3) · Behavioral Symptoms (3) · Depressive Disorder (3) · Mood Disorders (3) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide (1) · Desvenlafaxine Succinate (1) · Fatty Acids, Omega-3 (1) · Ketamine (1)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Helse Stavanger HF (1) · Markus KOSEL (1) · UConn Health (1)
Norway (1) · Spain (1) · Switzerland (1) · United States (1)
Dolors Puigdemont, MD (1) · Jayesh Kamath, MD PhD (1) · Markus Kosel, MD-PhD (1) · Pravin Israel, Ph.D (1)